Smith & Nephew plc (SN) Downgraded to Hold at Berenberg Bank
Berenberg Bank cut shares of Smith & Nephew plc (LON:SN) to a hold rating in a research report report published on Thursday morning. They currently have GBX 1,340 ($17.49) price objective on the stock, down from their previous price objective of GBX 1,485 ($19.38).
Several other equities research analysts also recently commented on SN. JPMorgan Chase & Co. upped their price target on shares of Smith & Nephew plc from GBX 1,196 ($15.61) to GBX 1,199 ($15.65) and gave the company a neutral rating in a research report on Friday, July 29th. BNP Paribas restated an outperform rating and issued a GBX 1,425 ($18.60) price target on shares of Smith & Nephew plc in a research report on Friday, July 29th. Beaufort Securities restated a hold rating on shares of Smith & Nephew plc in a research report on Tuesday, August 9th. Barclays PLC downgraded shares of Smith & Nephew plc to an equal weight rating and upped their price target for the company from GBX 1,230 ($16.06) to GBX 1,240 ($16.19) in a research report on Wednesday, August 10th. Finally, Credit Suisse Group AG restated a neutral rating and issued a GBX 1,285 ($16.77) price target on shares of Smith & Nephew plc in a research report on Friday, July 29th. Ten equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The company currently has an average rating of Hold and a consensus target price of GBX 1,283.77 ($16.76).
Smith & Nephew plc (LON:SN) traded up 1.55% during trading on Thursday, hitting GBX 1241.00. 4,851,477 shares of the company traded hands. Smith & Nephew plc has a one year low of GBX 1,040.36 and a one year high of GBX 1,324.00. The firm’s market cap is GBX 11.09 billion. The firm has a 50 day moving average of GBX 1,239.73 and a 200 day moving average of GBX 1,208.66.
In other news, insider Bottomley ,Virginia purchased 238 shares of the business’s stock in a transaction that occurred on Monday, August 15th. The stock was purchased at an average cost of GBX 1,290 ($16.84) per share, with a total value of £3,070.20 ($4,007.57).
Smith & Nephew plc Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. The Company offers various product franchises, which include Knee implants, Hip implants, Sports Medicine Joint Repair, Arthroscopy Enabling Technologies, Trauma and Extremities, Other Surgical Businesses, Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives.
Receive News & Stock Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related stocks with our FREE daily email newsletter.